Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain

Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.

Journal of dental research·2022

Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.

Journal of dental research·2021

Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.

Journal of virus eradication·2021

Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review.

Techniques in coloproctology·2019

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Current HIV research·2019

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

HIV medicine·2019

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Conflict of Interest vs Conflict of Incentives: Rethinking Dual Practice in Light of Malawi's Presidential Executive Order No. 1 of 2026.

Malawi medical journal : the journal of Medical Association of Malawi·2026

Short-Term Medicare-Allowed Amounts Associated With Initial Treatments for Stress Urinary Incontinence: Analysis of a Large National Medicare Fee-for-Service Claims Database.

Urogynecology (Philadelphia, Pa.)·2026

Changes in tubal permanent contraception rates in South Carolina following the Dobbs decision: a retrospective cohort study.

Frontiers in reproductive health·2026

Insurance Coverage for In Vitro Fertilization is Associated with Higher Live Birth Rates in a National Sample of Privately Insured Patients.

Fertility and sterility·2026

Phosphorylation in the dynein light intermediate chain 2 isoform enables Pin1 binding and modulates cargo-adaptor interactions.

Journal of structural biology: X·2026

Contract incentives and behaviours of medical consultants in Ireland.

Nature human behaviour·2026

Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain

Related Experiment Videos

Related Concept Videos

Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.

Mouthwashes with CPC Reduce the Infectivity of SARS-CoV-2 Variants In Vitro.

Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium.

Clinical results of infrared coagulation as a treatment of high-grade anal dysplasia: a systematic review.

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Conflict of Interest vs Conflict of Incentives: Rethinking Dual Practice in Light of Malawi's Presidential Executive Order No. 1 of 2026.

Short-Term Medicare-Allowed Amounts Associated With Initial Treatments for Stress Urinary Incontinence: Analysis of a Large National Medicare Fee-for-Service Claims Database.

Changes in tubal permanent contraception rates in South Carolina following the Dobbs decision: a retrospective cohort study.

Insurance Coverage for In Vitro Fertilization is Associated with Higher Live Birth Rates in a National Sample of Privately Insured Patients.

Phosphorylation in the dynein light intermediate chain 2 isoform enables Pin1 binding and modulates cargo-adaptor interactions.

Contract incentives and behaviours of medical consultants in Ireland.

Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain

Related Experiment Videos

Related Concept Videos

Related Articles